Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hensel Davest Indonesia Tbk. (HDIT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Hensel Davest Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Hensel Davest Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Hensel Davest Indonesia Tbk. trades at Rp51 (market cap 79.28B, 10.18M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 8× Hensel Davest Indonesia Tbk.'s market cap, and Hensel Davest Indonesia Tbk. is more actively traded (10.18M versus 843K). Which is the better fit depends on your goals.

HDITLABS
Market Cap
79.28B635.95B
Volume
10.18M843K
Lot
101.76K8.43K
Turnover
520.7M137.6M
Average Price
51.17163.22
Value
520.7M137.6M
Indicative Equilibrium Price
51165
Indicative Equilibrium Volume
10.02K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HDIT
View details
LABS
View details

About Hensel Davest Indonesia Tbk.

PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.

Read more on HDIT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS